IBERDOMIDE for Plasma cell myeloma refractory: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 14 adverse event reports in the FDA FAERS database where IBERDOMIDE was used for Plasma cell myeloma refractory.
Most Reported Side Effects for IBERDOMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 15 | 14.0% | 1 | 14 |
| Pneumonia | 11 | 10.3% | 2 | 8 |
| Covid-19 | 10 | 9.4% | 1 | 9 |
| Neutropenia | 10 | 9.4% | 2 | 2 |
| Sepsis | 7 | 6.5% | 1 | 5 |
| Infection | 6 | 5.6% | 1 | 0 |
| Rash | 5 | 4.7% | 1 | 0 |
Other Indications for IBERDOMIDE
Other Drugs Used for Plasma cell myeloma refractory
DEXAMETHASONE (2,276)
POMALIDOMIDE (1,562)
LENALIDOMIDE (1,220)
CARFILZOMIB (1,208)
BORTEZOMIB (848)
DARATUMUMAB (789)
ISATUXIMAB (778)
CYCLOPHOSPHAMIDE (518)
IXAZOMIB (356)
DOXORUBICIN (314)